Bausch Health Companies | VRX - Current Assets

Stock Price
7.89
Daily Change
0.08 1.02%
Monthly
-22.72%
Yearly
-25.71%
Q1 Forecast
7.62

Bausch Health Companies reported $6.25B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Amgen USD 27.88B 1.15B Sep/2025
ANI Pharmaceuticals USD 698.4M 95.77M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Bausch Health Companies USD 6.25B 265M Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
Novo Nordisk DKK 181.88B 19.18B Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Prestige Brands USD 497.41M 16.89M Sep/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Vertex Pharmaceuticals USD 10.57B 141.7M Sep/2025
Zoetis USD 6.58B 660M Sep/2025